Bio-Rad Laboratories | BIO - Stock


Bio-Rad Laboratories reported $770.5M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Abbott USD 6.99B 501M Mar/2026
Agilent USD 1.09B 30M Mar/2026
Becton, Dickinson and Co. USD 3.36B 728M Mar/2026
Bio Techne USD 201.18M 4.27M Mar/2026
Bio-Rad Laboratories USD 770.5M 29.8M Mar/2026
Bruker USD 1.12B 26.9M Mar/2026
Charles River Laboratories USD 359.72M 60.62M Mar/2026
Danaher USD 2.61B 119M Mar/2026
General Electric Aerospace USD 12.44B 73M Jun/2026
Illumina USD 611M 47M Mar/2026
Laboratory Of America USD 497.7M 37M Mar/2026
Merck USD 6.48B 179M Mar/2026
Mettler Toledo International USD 404.83M 17.6M Mar/2026
Myriad Genetics USD 27.9M 2.7M Mar/2026
OraSure Technologies USD 30.31M 753K Mar/2026
Pacific Biosciences Of California USD 51.02M 1.74M Mar/2026
Quest Diagnostics USD 225M 36M Mar/2026
Repligen USD 179.26M 8.8M Mar/2026
Revvity USD 387.5M 8.01M Mar/2026
Roche Holding CHF 7.6B 9M Jun/2025
Siemens EUR 11.1B 841M Dec/2025
Standard Biotools USD 18.59M 1.39M Mar/2026
Thermo Fisher Scientific USD 5.5B 71M Mar/2026
Tosoh JPY 248.86B 3.81B Sep/2025
Waters USD 1.5B 923.63M Mar/2026